V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008052 | 280008792 | 0 | 77.25 | Neo-adjuvant (N) | 2015-10-11 | 2016-07-13 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280026142 | RMS 2005 TRIAL |
| 280008053 | 280011293 | 1.53 | null | Curative (C) | 2014-10-30 | 2015-01-11 | CARBOPLATIN + RT | 02 | Y | 280026143 | CARBOPLATIN + RT |
| 280008054 | 280011696 | 1.84 | 83.6 | Neo-adjuvant (N) | null | 2013-11-11 | DOXORUBICIN | N | N | 280026145 | DOXORUBICIN |
| 280008055 | 280011696 | 1.71 | 71.6 | Curative (C) | 2014-03-27 | 2014-03-27 | Cetuximab + Radiotherapy Maint | N | null | 280026145 | CETUXIMAB + RT |
| 280008056 | 280005297 | 1.75 | 79 | Neo-adjuvant (N) | 2015-08-25 | 2015-08-29 | DOXORUBICIN | 2 | N | 280026147 | DOXORUBICIN |
| 280008057 | 280008793 | 1.71 | 52.5 | Neo-adjuvant (N) | 2018-02-01 | 2018-02-27 | CETUXIMAB + RT | N | N | 280026147 | CETUXIMAB + RT |
| 280008058 | 280011294 | 1.85 | 76 | Curative (C) | 2013-01-26 | 2013-10-06 | Cetuximab + Radiotherapy Maint | 02 | Y | 280026152 | CETUXIMAB + RT |
| 280008059 | 280008794 | 1.76 | 28.5 | Neo-adjuvant (N) | 2015-09-02 | 2015-09-22 | Cisplatin | N | null | 280026157 | CISPLATIN |
| 280008060 | 280008794 | 1.8 | 71 | Curative (C) | null | 2017-01-11 | Cisplatin | Y | N | 280026157 | CISPLATIN |
| 280008061 | 280005299 | 1.7 | 85.2 | Palliative (P) | 2017-02-15 | 2017-02-15 | PACLITAXEL | 02 | N | 280026163 | PACLITAXEL |
| 280008062 | 280008795 | 1.14 | 16.8 | Curative (C) | 2016-10-11 | 2016-11-27 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280026163 | IVA |
| 280008063 | 280011697 | 1.7 | 56.9 | Neo-adjuvant (N) | 2015-09-14 | 2015-10-02 | DOXORUBICIN | N | N | 280026168 | DOXORUBICIN |
| 280008064 | 280011697 | null | 79 | Palliative (P) | 2016-05-30 | 2017-11-08 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280026168 | PACLITAXEL |
| 280008065 | 280005301 | 1.91 | 142.4 | Curative (C) | 2013-05-02 | 2013-05-03 | Ifosfamide | 02 | N | 280026175 | IFOSFAMIDE |
| 280008066 | 280005303 | 1.84 | 132.5 | Palliative (P) | 2014-07-19 | 2014-07-19 | Ifosfamide | 02 | N | 280026178 | IFOSFAMIDE |
| 280008067 | 280005303 | 1.56 | 67 | Curative (C) | 2013-12-05 | 2013-12-05 | Ifosfamide | N | N | 280026178 | IFOSFAMIDE |
| 280008068 | 280005303 | null | 68 | Curative (C) | 2014-02-17 | 2014-02-18 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280026178 | IVA |
| 280008069 | 280005304 | 1.75 | 70.5 | Palliative (P) | 2016-08-18 | 2016-08-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280026183 | PACLITAXEL |
| 280008070 | 280005304 | 1.53 | 48.8 | Curative (C) | 2013-10-26 | 2013-12-18 | CARBOPLATIN + RT | N | N | 280026183 | CARBOPLATIN + RT |
| 280008071 | 280005304 | null | 81.45 | Curative (C) | 2015-01-28 | 2015-04-25 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280026183 | IVA |
| 280008072 | 280005304 | 1.05 | 86.6 | Neo-adjuvant (N) | 2016-12-28 | 2017-01-01 | STS Rhabdo RMS 2005 2nd Topo Cyclo | null | null | 280026183 | RMS 2005 TRIAL |
| 280008073 | 280005304 | 1.56 | 72.8 | null | 2018-06-17 | 2018-06-21 | Ifosfamide | 1 | N | 280026183 | IFOSFAMIDE |
| 280008074 | 280008798 | 1.72 | null | Curative (C) | 2016-07-31 | 2016-08-19 | Cetuximab + Radiotherapy Load | 02 | null | 280026194 | CETUXIMAB + RT |
| 280008075 | 280010477 | 1.59 | 0 | Curative (C) | 2017-03-27 | 2017-06-12 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280026195 | IVA |
| 280008076 | 280005307 | null | 76.8 | Curative (C) | 2017-03-13 | 2017-04-07 | Cisplatin 7 day | N | null | 280026197 | CISPLATIN |
| 280008077 | 280005307 | 1.75 | 171 | Palliative (P) | 2017-06-17 | 2017-11-25 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280026197 | PACLITAXEL |
| 280008078 | 280005308 | 0 | 81.8 | null | 2018-02-12 | 2018-05-02 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | Y | 280026202 | IVA |
| 280008079 | 280005309 | 1.74 | 81 | Curative (C) | 2016-02-02 | 2016-02-03 | Cetuximab + Radiotherapy Maint | 02 | Y | 280026205 | CETUXIMAB + RT |
| 280008080 | 280005311 | 1.8 | 100 | Curative (C) | 2018-03-08 | 2018-04-05 | Cisplatin 7 day | null | null | 280026206 | CISPLATIN |
| 280008081 | 280005312 | null | 86.7 | Curative (C) | 2016-07-15 | 2016-09-11 | CARBOPLATIN + RT | 2 | Y | 280026209 | CARBOPLATIN + RT |
| 280008082 | 280005312 | 1.95 | null | Neo-adjuvant (N) | 2015-06-10 | 2015-06-11 | Ifosfamide | N | N | 280026209 | IFOSFAMIDE |
| 280008083 | 280005312 | 1.62 | 17.7 | Neo-adjuvant (N) | 2017-05-06 | 2017-05-06 | Paclitaxel (2 or 3 weekly) | N | N | 280026209 | PACLITAXEL |
| 280008084 | 280005313 | 0 | 85.1 | Curative (C) | 2013-08-16 | 2013-08-19 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | Y | 280026220 | RMS 2005 TRIAL |
| 280008085 | 280005314 | 1.71 | 85.3 | Curative (C) | 2017-03-05 | 2018-06-18 | STS Rhabdo RMS 2005 Vin Cyclo | 2 | N | 280026221 | RMS 2005 TRIAL |
| 280008086 | 280005315 | null | null | Curative (C) | 2014-01-11 | 2014-01-16 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280026221 | RMS 2005 TRIAL |
| 280008087 | 280005319 | 1.7 | 62 | Adjuvant (A) | 2017-10-22 | 2017-11-09 | DOXORUBICIN | Y | null | 280026228 | DOXORUBICIN |
| 280008088 | 280005320 | 1.56 | 45.7 | Palliative (P) | 2012-09-03 | 2015-01-16 | Ifosfamide | 02 | N | 280026231 | IFOSFAMIDE |
| 280008089 | 280005322 | 0 | 12.7 | Disease modification (D) | 2013-08-11 | 2014-02-08 | STS Rhabdo RMS 2005 2nd Topo Cyclo | 02 | null | 280026232 | RMS 2005 TRIAL |
| 280008090 | 280005323 | 1.56 | 80.6 | Palliative (P) | 2014-10-26 | 2014-10-26 | DOXORUBICIN | null | null | 280026243 | DOXORUBICIN |
| 280008091 | 280005325 | 1.69 | 14.2 | null | 2017-01-03 | 2017-01-24 | Cisplatin 7 day | null | null | 280026247 | CISPLATIN |
| 280008092 | 280005328 | null | 75 | Palliative (P) | 2015-08-29 | 2015-09-20 | DOXORUBICIN | N | N | 280026249 | DOXORUBICIN |
| 280008093 | 280005329 | 1.8 | 94.2 | Curative (C) | null | 2015-10-03 | Cetuximab + Radiotherapy Maint | N | Y | 280026255 | CETUXIMAB + RT |
| 280008094 | 280005330 | 1.82 | 90.5 | Neo-adjuvant (N) | 2014-03-13 | 2014-03-26 | DOXORUBICIN | N | N | 280026256 | DOXORUBICIN |
| 280008095 | 280005331 | null | 131 | Neo-adjuvant (N) | null | 2014-12-12 | DOXORUBICIN | N | N | 280026259 | DOXORUBICIN |
| 280008096 | 280010480 | 1.52 | 108 | Curative (C) | 2017-04-08 | 2017-05-05 | Cetuximab + Radiotherapy Maint | null | null | 280026263 | CETUXIMAB + RT |
| 280008097 | 280010480 | 1.72 | 40.8 | Curative (C) | 2014-07-24 | 2014-10-30 | Ifosfamide | N | Y | 280026263 | IFOSFAMIDE |
| 280008098 | 280010480 | 1.6 | 64 | null | 2015-11-17 | 2015-11-29 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 280026263 | PACLITAXEL |
| 280008099 | 280010480 | 1.76 | null | Neo-adjuvant (N) | null | 2015-07-23 | Cisplatin | 2 | Y | 280026263 | CISPLATIN |
| 280008100 | 280008807 | 1.7 | 97.2 | Neo-adjuvant (N) | 2014-06-16 | 2014-09-04 | Paclitaxel 7 day | 02 | N | 280026269 | PACLITAXEL |
| 280008101 | 280010481 | null | 95.3 | Not known (9) | 2010-11-23 | 2013-09-23 | CARBOPLATIN + RT | 02 | Y | 280026274 | CARBOPLATIN + RT |